annual CFI:
$28.82M-$151.41M(-84.01%)Summary
- As of today (September 3, 2025), ARQT annual cash flow from investing activities is $28.82 million, with the most recent change of -$151.41 million (-84.01%) on December 31, 2024.
- During the last 3 years, ARQT annual CFI has risen by +$104.77 million (+137.94%).
- ARQT annual CFI is now -84.01% below its all-time high of $180.23 million, reached on December 31, 2023.
Performance
ARQT Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$17.42M+$5.67M(+48.28%)Summary
- As of today (September 3, 2025), ARQT quarterly cash flow from investing activities is $17.42 million, with the most recent change of +$5.67 million (+48.28%) on June 30, 2025.
- Over the past year, ARQT quarterly CFI has increased by +$79.56 million (+128.04%).
- ARQT quarterly CFI is now -83.83% below its all-time high of $107.75 million, reached on March 31, 2023.
Performance
ARQT quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$148.83M+$79.56M(+114.86%)Summary
- As of today (September 3, 2025), ARQT TTM cash flow from investing activities is $148.83 million, with the most recent change of +$79.56 million (+114.86%) on June 30, 2025.
- Over the past year, ARQT TTM CFI has increased by +$256.30 million (+238.48%).
- ARQT TTM CFI is now -47.71% below its all-time high of $284.62 million, reached on September 30, 2023.
Performance
ARQT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ARQT Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.0% | +128.0% | +238.5% |
| 3 y3 years | +137.9% | -66.8% | +56.9% |
| 5 y5 years | +209.5% | +185.4% | +612.6% |
ARQT Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.0% | +133.1% | -83.8% | +108.8% | -47.7% | +238.5% |
| 5 y | 5-year | -84.0% | +115.8% | -83.8% | +108.8% | -47.7% | +155.0% |
| alltime | all time | -84.0% | +115.8% | -83.8% | +108.8% | -47.7% | +155.0% |
ARQT Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $17.42M(+48.3%) | $148.83M(+114.9%) |
| Mar 2025 | - | $11.75M(-66.3%) | $69.27M(+140.3%) |
| Dec 2024 | $28.82M(-84.0%) | $34.88M(-58.9%) | $28.82M(-142.2%) |
| Sep 2024 | - | $84.78M(-236.4%) | -$68.24M(-36.5%) |
| Jun 2024 | - | -$62.14M(+116.5%) | -$107.47M(-345.5%) |
| Mar 2024 | - | -$28.70M(-53.9%) | $43.78M(-75.7%) |
| Dec 2023 | $180.23M(-306.7%) | -$62.19M(-236.5%) | $180.23M(-36.7%) |
| Sep 2023 | - | $45.55M(-48.9%) | $284.62M(+580.8%) |
| Jun 2023 | - | $89.12M(-17.3%) | $41.81M(+695.6%) |
| Mar 2023 | - | $107.75M(+155.3%) | $5.25M(-106.0%) |
| Dec 2022 | -$87.20M(+14.8%) | $42.20M(-121.4%) | -$87.20M(-17.7%) |
| Sep 2022 | - | -$197.26M(-475.3%) | -$105.90M(-211.7%) |
| Jun 2022 | - | $52.56M(+243.6%) | $94.83M(-177.3%) |
| Mar 2022 | - | $15.30M(-34.9%) | -$122.65M(+61.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$75.95M(-58.2%) | $23.50M(+577.0%) | -$75.95M(-56.7%) |
| Sep 2021 | - | $3.47M(-102.1%) | -$175.34M(-35.2%) |
| Jun 2021 | - | -$164.92M(-366.0%) | -$270.53M(+171.9%) |
| Mar 2021 | - | $62.00M(-181.7%) | -$99.50M(-45.3%) |
| Dec 2020 | -$181.82M(+590.7%) | -$75.89M(-17.2%) | -$181.82M(+28.1%) |
| Sep 2020 | - | -$91.71M(-1602.2%) | -$141.93M(+388.8%) |
| Jun 2020 | - | $6.11M(-130.0%) | -$29.04M(-22.3%) |
| Mar 2020 | - | -$20.33M(-43.5%) | -$37.38M(+42.0%) |
| Dec 2019 | -$26.32M(+128.3%) | -$36.00M(-269.9%) | -$26.32M(+1316.8%) |
| Sep 2019 | - | $21.18M(-1045.3%) | -$1.86M(-91.9%) |
| Jun 2019 | - | -$2.24M(-75.8%) | -$23.04M(+10.8%) |
| Mar 2019 | - | -$9.27M(-19.6%) | -$20.80M(+80.4%) |
| Dec 2018 | -$11.53M(<-9900.0%) | -$11.53M | -$11.53M |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual CFI year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly CFI year-on-year change?
- What is Arcutis Biotherapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. TTM CFI year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of ARQT is $28.82M
What is the all time high annual CFI for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual cash flow from investing activities is $180.23M
What is Arcutis Biotherapeutics, Inc. annual CFI year-on-year change?
Over the past year, ARQT annual cash flow from investing activities has changed by -$151.41M (-84.01%)
What is Arcutis Biotherapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of ARQT is $17.42M
What is the all time high quarterly CFI for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly cash flow from investing activities is $107.75M
What is Arcutis Biotherapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, ARQT quarterly cash flow from investing activities has changed by +$79.56M (+128.04%)
What is Arcutis Biotherapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of ARQT is $148.83M
What is the all time high TTM CFI for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high TTM cash flow from investing activities is $284.62M
What is Arcutis Biotherapeutics, Inc. TTM CFI year-on-year change?
Over the past year, ARQT TTM cash flow from investing activities has changed by +$256.30M (+238.48%)